| Field | Specification |
|---|---|
| Target | |
| Alternative names | AT rich interactive domain 2; ARID, RFX-like; arid2 |
| Gene ID | |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | E.coli-derived zebrafish ARID2 recombinant protein (Position: E11-R30). |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
This rabbit polyclonal antibody conjugated to APC targets AT rich interactive domain 2 (gene arid2) in zebrafish samples.
ARID2 is a subunit specific to the PBAF form of the SWI/SNF chromatin remodeling complex. It helps the complex alter nucleosome positioning to control gene expression, and inactivating ARID2 mutations are found in several cancers, making it a subject of chromatin and cancer research.
| Target | AT rich interactive domain 2 (gene arid2; UniProt A0JPE6, zebrafish) |
|---|---|
| Host / Clonality / Isotype | Rabbit / Polyclonal / Rabbit IgG |
| Conjugate | APC |
| Reactivity | Zebrafish |
Immunogen
Recombinant zebrafish ARID2 fragment (Glu11–Arg30), expressed in E. coli.
Reactivity Notes
The supplier lists reactivity with zebrafish. UniProt places AT rich interactive domain 2 in the nucleus.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
